{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T23:27:11Z","timestamp":1770593231298,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1118","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>For radioactive Iodine-131 (131I) treatments of thyroid diseases, increased efficacy has been reported for personalized dosimetry treatments. The measurement of Iodine-131 thyroid uptake (131IU) is required in these cases. This study aims to investigate whether 99mTc thyroid uptake (99mTcU) may be used in place of 131IU for implementing personalised treatments.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>A retrospective study of 152 benign thyroid disease 131I treatments was carried out during 2012\u20132020; 117 treatments were for female patients while 35 were for male patients diagnosed with either Graves\u2019 disease, multinodular goitre or toxic nodules.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>A statistically significant correlation was found between 131IU and 99mTcU data, with the data more correlated for male than female patients (r = 0.71 vs 0.38, p-value &amp;lt; 0.001). Patient age and time difference between the two respective uptake measurements significantly influenced the uptake correlation in females but not for the male cohort, although there was no significant difference between the parameters across gender. Thyroid diagnosis and hormone levels showed a significant correlation with uptakes in both genders. Estimating 131IU based on 99mTcU was shown to be predictive for male but not in female patients (R2 = 91% vs 16%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Estimating 131IU based on 99mTcU is not recommended for females at our centre. Males reported good correlation, but a larger sample would be needed for validation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>The initial findings showed a significant gender difference in benign thyroid uptake parameters at our centre, highlighting the potential need for gender consideration when planning 131IU patient management and when reporting studies results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20200700","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T20:21:16Z","timestamp":1606422076000},"source":"Crossref","is-referenced-by-count":8,"title":["Gender differences in estimating I-131 thyroid uptake from Tc-99m thyroid uptake for benign thyroid disease"],"prefix":"10.1093","volume":"94","author":[{"given":"Amna","family":"Al-Jabri","sequence":"first","affiliation":[{"name":"School of Medicine, Trinity College , Dublin , Ireland"},{"name":"St James\u2019s Hospital , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie","family":"Cooke","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se\u00e1n","family":"Cournane","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s University Hospital , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Louise","family":"Healy","sequence":"additional","affiliation":[{"name":"St James\u2019s Hospital , Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"2024050215415643100_b1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/rpd\/nch013","article-title":"Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism","volume":"108","author":"J\u00f6nsson","year":"2004","journal-title":"Radiat Prot Dosimetry"},{"key":"2024050215415643100_b2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-008-0761-x","article-title":"EANM dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy","volume":"35","author":"Lassmann","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00259-013-2387-x","article-title":"EANM dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. dosimetry prior to radioiodine therapy of benign thyroid diseases","volume":"40","author":"H\u00e4nscheid","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00259-010-1398-0","article-title":"Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma","volume":"37","author":"Salvatori","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b5","article-title":"59\/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing directives 89\/618\/Euratom, 90\/641\/Euratom, 96\/29\/Euratom, 97\/43\/Euratom and 2003\/122\/Euratom","author":"Directive","year":"2013","journal-title":"Euratom"},{"key":"2024050215415643100_b6","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","article-title":"EANM procedure guidelines for therapy of benign thyroid disease","volume":"37","author":"Stokkel","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40658-017-0193-4","article-title":"Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey","volume":"4","author":"Sj\u00f6green Gleisner","year":"2017","journal-title":"EJNMMI Phys"},{"key":"2024050215415643100_b8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00003072-199002000-00003","article-title":"Estimation of 24-hour thyroid uptake of I-131 sodium iodide using a 5-minute uptake of technetium-99m pertechnetate","volume":"15","author":"Smith","year":"1990","journal-title":"Clin Nucl Med"},{"issue":"supplement 2","key":"2024050215415643100_b9","first-page":"434","article-title":"Assessment of 24-hour thyroid uptake of I-131 sodium iodide using a 5-minute uptake of technetium-99m pertechnetate","volume":"50","author":"Gorur","year":"2009","journal-title":"J Nucl Med"},{"key":"2024050215415643100_b10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12020-016-1074-7","article-title":"Calculation of therapeutic activity of radioiodine in Graves' disease by means of Marinelli's formula, using technetium (99mTc) scintigraphy","volume":"54","author":"Szumowski","year":"2016","journal-title":"Endocrine"},{"key":"2024050215415643100_b11","first-page":"260","article-title":"Dosage determination with radioactive isotopes; practical considerations in therapy and protection","volume":"59","author":"Marinelli","year":"1948","journal-title":"Am J Roentgenol Radium Ther"},{"key":"2024050215415643100_b12","first-page":"785","article-title":"Simultaneous measurement of thyroidal trapping (99mTcO4-) and binding (131I-): clinical and experimental studies in man","volume":"14","author":"Hays","year":"1973","journal-title":"J Nucl Med"},{"key":"2024050215415643100_b13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.2890030406","article-title":"Management of thyroid nodules. II: scanning techniques, thyroid suppressive therapy, and fine needle aspiration","volume":"3","author":"Ashcraft","year":"1981","journal-title":"Head Neck Surg"},{"key":"2024050215415643100_b14","first-page":"907","article-title":"20-Min 99mTc thyroid uptake: a simplified method using the gamma camera","volume":"14","author":"Higgins","year":"1973","journal-title":"J Nucl Med"},{"key":"2024050215415643100_b15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1677\/joe.0.0490531","article-title":"A comparison between the uptake of technetium-99m and iodine-131 by the thyroid gland","volume":"49","author":"McGill","year":"1971","journal-title":"J Endocrinol"},{"key":"2024050215415643100_b16","first-page":"6","article-title":"Thyroid uptake of Tc-99m and its agreement with I-131 for evaluation of hyperthyroid function","volume":"5","author":"Ohiduzzaman","year":"2019","journal-title":"Situations"},{"key":"2024050215415643100_b17","article-title":"Editor guidelines for the management of thyroid cancer","author":"Association BT,","year":"2007","journal-title":"Royal College of Physicians"},{"key":"2024050215415643100_b18","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1007\/s00259-019-04472-8","article-title":"EANM practice guideline\/SNMMI procedure standard for RAIU and thyroid scintigraphy","volume":"46","author":"Giovanella","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b19","first-page":"307","article-title":"Measurement in medicine: the analysis of method comparison studies","volume":"32","author":"Altman","year":"1983","journal-title":"Journal of the Royal Statistical Society: Series D"},{"key":"2024050215415643100_b20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1118\/1.1567270","article-title":"Tissue-Specific dosimetry for radioiodine therapy of the autonomous thyroid nodule","volume":"30","author":"Matheoud","year":"2003","journal-title":"Med Phys"},{"key":"2024050215415643100_b21","first-page":"1632","article-title":"Optimized dose planning of radioiodine therapy of benign thyroidal diseases","volume":"34","author":"Bockisch","year":"1993","journal-title":"J Nucl Med"},{"key":"2024050215415643100_b22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1088\/0031-9155\/47\/9\/305","article-title":"A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease","volume":"47","author":"Di Martino","year":"2002","journal-title":"Phys Med Biol"},{"key":"2024050215415643100_b23","first-page":"473","article-title":"Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism","volume":"18","author":"J\u00f6nsson","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"2024050215415643100_b24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623910","article-title":"Concept and validation of a simple model of the intrathyroidal iodine kinetics","volume":"43","author":"Rink","year":"2004","journal-title":"Nuklearmedizin"},{"key":"2024050215415643100_b25","first-page":"1","article-title":"Population biokinetic modeling of thyroid uptake and retention of radioiodine","volume":"20","author":"Areberg","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"2024050215415643100_b26","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med"},{"key":"2024050215415643100_b27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006231-200607000-00003","article-title":"Optimized radioiodine therapy for Graves' disease: two MIRD-based models for the computation of patient-specific therapeutic 131I activity","volume":"27","author":"Carlier","year":"2006","journal-title":"Nucl Med Commun"},{"key":"2024050215415643100_b28","article-title":"MIRD: radionuclide data and decay schemes: Snmmi","author":"Eckerman","year":"2007"},{"key":"2024050215415643100_b29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1088\/0031-9155\/56\/3\/003","article-title":"Accuracy and optimal timing of activity measurements in estimating the absorbed dose of radioiodine in the treatment of Graves' disease","volume":"56","author":"Merrill","year":"2011","journal-title":"Phys Med Biol"},{"key":"2024050215415643100_b30","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1118\/1.2210564","article-title":"Verification of the agreement of two dosimetric methods with radioiodine therapy in hyperthyroid patients","volume":"33","author":"Canzi","year":"2006","journal-title":"Med Phys"},{"key":"2024050215415643100_b31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00259-002-0775-8","article-title":"Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET","volume":"29","author":"Eschmann","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2024050215415643100_b32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol"},{"key":"2024050215415643100_b33","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/94\/1118\/20200700\/57373359\/bjr.20200700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/94\/1118\/20200700\/57373359\/bjr.20200700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T17:31:30Z","timestamp":1714671090000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20200700\/7452305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":33,"journal-issue":{"issue":"1118","published-online":{"date-parts":[[2020,12,11]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20200700","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,12,11]]},"article-number":"20200700"}}